Type to search

Amniotics AB Announces Positive Pre-clinical Proof-of-concept Results for PulmoStem™ in End-stage Lung Disease | Pharmtech Focus
Amniotics Secures Funding of SEK 4,8 Million from Vinnova to Develop Stem Cell Therapies | Pharmtech Focus
Amniotics Joins Vinnova Funded ’CAMP’ to Improve Outcome of Lung Transplantations with PulmoStem™ | Pharmtech Focus